IRIS
DOTTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.245
EU - Europa 15.593
AS - Asia 9.231
SA - Sud America 1.481
AF - Africa 575
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 18
Totale 50.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.992
GB - Regno Unito 3.278
CN - Cina 3.172
SG - Singapore 2.908
RU - Federazione Russa 2.848
IT - Italia 2.354
IE - Irlanda 2.048
UA - Ucraina 1.257
BR - Brasile 1.242
SE - Svezia 992
FR - Francia 883
HK - Hong Kong 830
VN - Vietnam 800
DE - Germania 734
FI - Finlandia 507
KR - Corea 484
ZA - Sudafrica 330
IN - India 259
ES - Italia 173
BD - Bangladesh 169
CA - Canada 124
NL - Olanda 113
TR - Turchia 99
NG - Nigeria 84
BE - Belgio 79
MX - Messico 75
AR - Argentina 72
IQ - Iraq 67
PK - Pakistan 66
JP - Giappone 65
PL - Polonia 56
AT - Austria 53
AU - Australia 47
SA - Arabia Saudita 44
ID - Indonesia 40
CI - Costa d'Avorio 39
EC - Ecuador 37
IR - Iran 33
CO - Colombia 30
CL - Cile 29
CZ - Repubblica Ceca 27
JO - Giordania 26
KE - Kenya 24
EG - Egitto 23
MA - Marocco 23
VE - Venezuela 23
CH - Svizzera 21
GR - Grecia 21
LT - Lituania 21
PE - Perù 19
AE - Emirati Arabi Uniti 18
MY - Malesia 18
IL - Israele 17
HU - Ungheria 16
PT - Portogallo 16
RO - Romania 16
DK - Danimarca 15
UZ - Uzbekistan 15
PY - Paraguay 14
DZ - Algeria 13
EU - Europa 12
PH - Filippine 12
JM - Giamaica 11
NP - Nepal 11
BY - Bielorussia 10
ET - Etiopia 9
TH - Thailandia 9
AL - Albania 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
BB - Barbados 7
CR - Costa Rica 7
TN - Tunisia 7
AZ - Azerbaigian 6
BO - Bolivia 6
EE - Estonia 6
KZ - Kazakistan 6
OM - Oman 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
LB - Libano 5
LU - Lussemburgo 5
MD - Moldavia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
KW - Kuwait 4
LV - Lettonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
AO - Angola 3
BN - Brunei Darussalam 3
CY - Cipro 3
GT - Guatemala 3
IM - Isola di Man 3
Totale 50.143
Salva come PNG Salva come JPEG
Città #
Dallas 3.139
Southend 2.888
Fairfield 2.662
Dublin 2.029
Ashburn 1.691
Houston 1.617
Singapore 1.473
Chandler 1.256
Woodbridge 1.186
Jacksonville 999
Seattle 996
Wilmington 944
Cambridge 902
Hong Kong 794
Moscow 792
Beijing 742
Santa Clara 707
San Jose 618
Hefei 573
Ann Arbor 547
Siena 476
Seoul 457
Princeton 455
The Dalles 365
Nanjing 355
Johannesburg 311
Council Bluffs 299
New York 282
Los Angeles 264
Helsinki 255
Lauterbourg 250
Florence 241
Ho Chi Minh City 214
Hanoi 189
Milan 187
Boardman 170
San Diego 144
Munich 137
San Mateo 132
Buffalo 129
Nanchang 124
Málaga 122
Rome 122
São Paulo 112
Shanghai 100
Dong Ket 99
Columbus 98
Abuja 80
London 74
Changsha 70
Redondo Beach 70
Shenyang 67
Atlanta 66
Orem 59
Tianjin 59
Bengaluru 56
Chicago 54
Hebei 54
Dearborn 51
Jiaxing 49
Kunming 48
Frankfurt am Main 47
Tokyo 47
Nuremberg 45
Zhengzhou 45
Warsaw 44
San Francisco 42
Toronto 42
Brussels 40
Abidjan 39
Chennai 39
Falls Church 38
Rio de Janeiro 38
Montreal 37
Norwalk 37
Turku 37
Guangzhou 36
Phoenix 36
Brooklyn 34
Da Nang 34
Washington 32
Amsterdam 30
Düsseldorf 30
Belo Horizonte 29
Vienna 29
Fremont 28
Hangzhou 28
Brasília 27
Izmir 27
Lappeenranta 27
Leuven 27
Amman 26
Baghdad 25
Jinan 25
Ningbo 25
Istanbul 24
Lahore 24
Stockholm 24
Dhaka 23
Haiphong 23
Totale 34.791
Salva come PNG Salva come JPEG
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.252
Markers of beta cell function in type 1 diabetes mellitus 630
Urban diabetes: The case of the metropolitan area of Rome 445
null 398
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 326
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. 320
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 317
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 313
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 306
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 304
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 299
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 299
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 296
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 293
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 293
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 288
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 283
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 282
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 281
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 279
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 279
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 269
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 268
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 265
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 265
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 256
Prognostic bioindicators in severe COVID-19 patients 256
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 255
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 254
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 252
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 252
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 252
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 247
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 246
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 245
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 243
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 241
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 240
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 238
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 238
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 236
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 235
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 235
MicroRNAs: markers of β-cell stress and autoimmunity 235
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 233
A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies 231
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 229
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 229
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 228
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 227
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 224
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 222
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 221
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 221
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 220
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 219
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 218
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 218
Endocrine actions of osteocalcin 218
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 218
A novel neuroendocrine cell surface glycoprotein: identification, isolation, and initial characterization 217
A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk of diabetes and in insulin dependent diabetics at onset. 217
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 216
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 215
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 214
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 213
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 211
A three-layer perspective on miRNA regulation in β cell inflammation 210
Coxsackieviruses and Insulitis 209
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans 205
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 204
Acute onset of seeming IDDM in an AIDS patient 204
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 204
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 203
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 203
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 203
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 202
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 202
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. 202
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 202
Guidelines for the treatment and management of new-onset diabetes after transplantation 201
Non-coding RNAs: novel players in insulin resistance and related diseases 200
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 199
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 198
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 198
La prevenzione del diabete mellito di tipo 1 197
The essential role of microRNAs in Diabetes Mellitus: regulators of β cell function and potential disease biomarkers 195
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 194
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 193
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 191
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 191
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 191
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 190
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 190
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 188
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 188
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 188
Cardiorenal end points in a trial of aliskiren for type 2 diabetes 188
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 187
Viral Infections and diabetes 184
Totale 25.089
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.971
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 0 0 0 0 0 0 0 0 0 338
2021/20223.296 260 556 209 289 117 101 173 105 145 317 320 704
2022/20234.482 282 318 472 645 475 929 66 353 474 165 192 111
2023/20243.121 149 109 245 133 160 843 967 99 25 124 39 228
2024/20256.875 133 387 620 430 741 347 219 467 659 329 675 1.868
2025/202615.575 1.262 2.233 2.626 1.549 2.531 623 1.702 695 743 887 495 229
Totale 50.923